Seeing progress on protein targets or fewer constipation episodes reinforces habits that reduce cravings and keep lean mass intact
[1] [2] While these often improve after the first few weeks, persistent symptoms may require dose adjustment, slower titration, or additional supportive measures
This collaborative care typically involves both your GP and, where appropriate, endocrinology services
Research participants at higher doses often saw 20-22% body weight reduction compared to 10-15% at lower starting doses, yet many people achieve meaningful results at moderate doses without escalating further
Microglial activation induces nitric oxide signalling and alters protein S-nitrosylation patterns in extracellular vesicles
Thus, these apparently successful metabolic approaches in this ALS mouse model cannot be fully recommended for ALS patients